MUC1 immunotherapy

被引:95
作者
Beatson, Richard E. [1 ]
Taylor-Papadimitriou, Joyce [1 ]
Burchell, Joy M. [1 ]
机构
[1] Kings Coll London, Guys Hosp, Breast Canc Biol Grp, London SE1 9RT, England
关键词
aberrant O-linked glycosylation; cancer; episialin; immunotherapy; MUC1; polymorphic epithelial mucin; BREAST-CANCER PATIENTS; HUMORAL IMMUNE-RESPONSE; CYTOTOXIC T-LYMPHOCYTES; TUMOR-ASSOCIATED MUC1; SQUAMOUS-CELL CARCINOMA; O-LINKED GLYCOSYLATION; PULSED DENDRITIC CELLS; GROWTH-FACTOR RECEPTOR; PHASE-I TRIAL; C-TYPE LECTIN;
D O I
10.2217/IMT.10.17
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The overexpression and aberrant glycosylation of MUC1 is associated with a wide variety of cancers, making it an ideal target for immunotherapeutic strategies. This review highlights the main avenues of research in this field, focusing on adenocarcinomas, from the preclinical to clinical; the problems and possible solutions associated with each approach; and speculates on the direction of MUC1 immunotherapeutic research over the next 5-10 years.
引用
收藏
页码:305 / 327
页数:23
相关论文
共 228 条
[51]  
DOMENECH N, 1995, J IMMUNOL, V155, P4766
[52]   Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients [J].
Domschke, Christoph ;
Schuetz, Florian ;
Sommerfeldt, Nora ;
Rom, Joachim ;
Scharf, Alexander ;
Sohn, Christof ;
Schneeweiss, Andreas ;
Beckhove, Philipp .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (03) :479-486
[53]   Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer-Specific Immune Responses and Their Correlation to Prognosis [J].
Domschke, Christoph ;
Schuetz, Florian ;
Ge, Yingzi ;
Seibel, Tobias ;
Falk, Christine ;
Brors, Benedikt ;
Vlodavsky, Israel ;
Sommerfeldt, Nora ;
Sinn, Hans-Peter ;
Kuehnle, Marie-Christine ;
Schneeweiss, Andreas ;
Scharf, Alexander ;
Sohn, Christof ;
Schirrmacher, Volker ;
Moldenhauer, Gerhard ;
Momburg, Frank ;
Beckhove, Philipp .
CANCER RESEARCH, 2009, 69 (21) :8420-8428
[54]   Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA [J].
Dörfel, D ;
Appel, S ;
Grünebach, F ;
Weck, MM ;
Müller, MR ;
Heine, A ;
Brossart, P .
BLOOD, 2005, 105 (08) :3199-3205
[55]   MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure [J].
Dreicer, R. ;
Stadler, W. M. ;
Ahmann, F. R. ;
Whiteside, T. ;
Bizouarne, N. ;
Acres, B. ;
Limacher, J. -M. ;
Squiban, P. ;
Pantuck, A. .
INVESTIGATIONAL NEW DRUGS, 2009, 27 (04) :379-386
[56]   Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR [J].
Dutoit, V ;
Rubio-Godoy, V ;
Doucey, MA ;
Batard, P ;
Liénard, D ;
Rimoldi, D ;
Speiser, D ;
Guillaume, P ;
Cerottini, JC ;
Romero, P ;
Valmori, D .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1167-1171
[57]   Identification and topology of variant sequences within individual repeat domains of the human epithelial tumor mucin MUC1 [J].
Engelmann, K ;
Baldus, SE ;
Hanisch, FG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) :27764-27769
[58]   MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1 [J].
Engelmann, Katja ;
Shen, Hongmei ;
Finn, Olivera J. .
CANCER RESEARCH, 2008, 68 (07) :2419-2426
[59]   Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases [J].
Fatrai, Szabolcs ;
Schepers, Hein ;
Tadema, Henko ;
Vellenga, Edo ;
Daenen, Simon M. G. J. ;
Schuringa, Jan Jacob .
EXPERIMENTAL HEMATOLOGY, 2008, 36 (10) :1254-1265
[60]   Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow [J].
Feuerer, M ;
Beckhove, P ;
Bai, LH ;
Solomayer, EF ;
Bastert, G ;
Diel, IJ ;
Pedain, C ;
Oberniedermayr, M ;
Schirrmacher, V ;
Umansky, V .
NATURE MEDICINE, 2001, 7 (04) :452-458